-transparent.png){kind=logo}
We report two patients with Felty's syndrome and chronic skin ulcers treated successfully with recombinant granulocyte colony stimulating factor (GCSF). In both cases granulocytes returned to the normal range within days of starting treatment, and their cutaneous ulcers improved. In one patient granulocytes were maintained at normal levels with a regimen of GCSF 3 micrograms/kg twice weekly for 14 months.
Related Publications
M F Choi, and
M J Mant, and
A R Turner, and
J J Akabutu, and
S L Aaron
August 1993,
The Journal of rheumatology,
M F Choi, and
M J Mant, and
A R Turner, and
J J Akabutu, and
S L Aaron
December 1990,
Arthritis and rheumatism,
M F Choi, and
M J Mant, and
A R Turner, and
J J Akabutu, and
S L Aaron
May 1993,
Annals of hematology,
M F Choi, and
M J Mant, and
A R Turner, and
J J Akabutu, and
S L Aaron
April 1996,
The Journal of rheumatology,
M F Choi, and
M J Mant, and
A R Turner, and
J J Akabutu, and
S L Aaron
April 1997,
British journal of haematology,
M F Choi, and
M J Mant, and
A R Turner, and
J J Akabutu, and
S L Aaron
February 1991,
Annals of hematology,
M F Choi, and
M J Mant, and
A R Turner, and
J J Akabutu, and
S L Aaron
October 1995,
Orvosi hetilap,
M F Choi, and
M J Mant, and
A R Turner, and
J J Akabutu, and
S L Aaron
August 1992,
American journal of hematology,
M F Choi, and
M J Mant, and
A R Turner, and
J J Akabutu, and
S L Aaron
March 1995,
Clinical rheumatology,
M F Choi, and
M J Mant, and
A R Turner, and
J J Akabutu, and
S L Aaron
January 1992,
Medical and pediatric oncology,
